Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)

被引:10
|
作者
Gurung, Arun B. [1 ]
Bhattacharjee, Atanu [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Computat Biol Lab, Shillong 793022, Meghalaya, India
[2] North Eastern Hill Univ, Bioinformat Ctr, Shillong, Meghalaya, India
关键词
atherosclerosis; complex human diseases; lipoprotein-associated phospholipase A(2); non-synonymous single nucleotide polymorphism; pharmacogenomics; Q281R mutation; ACTIVATING-FACTOR-ACETYLHYDROLASE; SINGLE NUCLEOTIDE POLYMORPHISMS; PAF-ACETYLHYDROLASE; CARDIOVASCULAR-DISEASE; GENETIC-VARIATION; PROTEIN; DEFICIENCY; SEQUENCE; MUTATION; BINDING;
D O I
10.1002/jcb.26909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-synonymous single nucleotide polymorphisms (nsSNPs) are genetic variations at single base resulting in an amino acid change which have been associated with various complex human diseases. The human Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) gene harbours a rare Q281R polymorphism which was previously reported to cause loss of enzymatic function. Lp-PLA(2) is an important enzyme which catalyzes the hydrolysis of polar phospholipids releasing pro-atherogenic and pro-inflammatory mediators involved in the pathogenesis of atherosclerosis. Our current study is aimed at elucidating the structural and functional consequences of Q281R polymorphism on Lp-PLA(2). The Q281R mutation is classified as deleterious and causes protein instability as deduced from evolutionary, folding free energy changes and Support vector machine (SVM)-based methods. A Q281R mutant structure was deciphered using homology modelling approach and was validated using phi and psi dihedral angles distribution, ERRAT, Verify_3D scores, Protein Structure Analysis (ProSA) energ,y and Z-score. A decreased hydrophobic interactions and weaker substrate binding affinity was observed in the mutant compared to the wild- type (WT) using molecular docking. Further, the mutant displayed enhanced structural flexibility particularly in the low density lipoprotein (LDL) binding domain, decreased solvent accessibility of catalytic residues-Phe274 and Ser273 and increased C? distance between Phe274 and Leu153 and large conformational entropy change as inferred from all-atom molecular dynamics (MD) simulation and essential dynamics (ED) studies. Our results corroborate well with previous experimental studies and thus these aberrations in the Q281R mutant structure may help explain the molecular basis of loss of enzyme activity.
引用
收藏
页码:7009 / 7021
页数:13
相关论文
共 50 条
  • [1] Effects of Dietary Factors on Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
    Wong, Cheuk-Kit
    White, Harvey D.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (06) : 461 - 466
  • [2] Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
    Tselepis, Alexandros D.
    Rizzo, Manfredi
    Goudevenos, Ioannis A.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (33) : 3656 - 3661
  • [3] Diurnal variation in lipoprotein-associated phospholipase A2 (Lp-PLA2)
    Kaminsky, Leonard A.
    Ozemek, Cemal
    CLINICAL BIOCHEMISTRY, 2012, 45 (09) : 700 - 702
  • [4] Effects of Dietary Factors on Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
    Cheuk-Kit Wong
    Harvey D. White
    Current Atherosclerosis Reports, 2011, 13 : 461 - 466
  • [5] Lipoprotein-associated phospholipase A2 (Lp-PLA2): Relevant biomarker and therapeutic target?
    Bonnefont-Rousselot, Dominique
    ANNALES PHARMACEUTIQUES FRANCAISES, 2025, 83 (01): : 45 - 57
  • [6] Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
    Tellis, Constantinos C.
    Tselepis, Alexandros D.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) : 6256 - 6269
  • [7] Lp-PLA2 (Lipoprotein-Associated Phospholipase A2) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits
    Chen, Jiahuan
    Zhang, Huanyu
    Li, Linquan
    Zhang, Xinwei
    Zhao, Dazhong
    Wang, Lingyu
    Wang, Jiaqi
    Yang, Ping
    Sun, Huan
    Liu, Kun
    Chen, Weiwei
    Li, Lin
    Lin, Feng
    Li, Zhanjun
    Chen, Y. Eugene
    Zhang, Jifeng
    Pang, Daxin
    Ouyang, Hongsheng
    He, Yuquan
    Fan, Jianglin
    Tang, Xiaochun
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (01) : E11 - E28
  • [8] Lipoprotein-associated phospholipase A2 (Lp-PLA2): A novel and promising biomarker for cardiovascular risks assessment
    Cai, Anping
    Zheng, Dongdan
    Qiu, Ruofeng
    Mai, Weiyi
    Zhou, Yingling
    DISEASE MARKERS, 2013, 34 (05) : 323 - 331
  • [9] Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker
    Vittos, Oana
    Toana, Bogdan
    Vittos, Alexandros
    Moldoveanu, Elena
    BIOMARKERS, 2012, 17 (04) : 289 - 302
  • [10] Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients
    Mitsuaki Ishihara
    Tadao Iwasaki
    Makoto Nagano
    Jun Ishii
    Mayumi Takano
    Takeshi Kujiraoka
    Masahiro Tsuji
    Hiroaki Hattori
    Mitsuru Emi
    Journal of Human Genetics, 2004, 49 : 302 - 307